Nigeria Is Not Experimenting With GMOs, It Is Regulating Them

GMO Crops

Nigeria’s conversation about genetically modified (GM) crops is gradually shifting from public skepticism to evidence-based decision-making in approval of GM crops, largely because the country has built a regulatory system that treats biotechnology not as an experiment, but as a controlled national programme.

Across rural communities and universities, regulators are engaging farmers and students with one central message: adoption follows trust, and trust follows credible oversight. That oversight is anchored by the National Biosafety Management Agency (NBMA), whose mandate is to evaluate, approve, and monitor every genetically modified crop before it reaches farms or markets.

Nigeria’s regulatory journey did not start recently. The country aligned with global biosafety governance as far back as 1992 when it signed the Convention on Biological Diversity and ratified it in 1994. This eventually produced a dedicated biosafety law in 2015, creating a specialised institution with legal authority to control importation, field trials, and commercialization of GM products.

In 2019, the law was reviewed and amended to regulate emerging technologies such as gene editing and synthetic biology, placing Nigeria among a limited number of developing countries with forward-looking biotechnology legislation.

Under this framework, no GM crop can legally enter, be tested, or be grown without formal approval by NBMA, and violations attract penalties including fines of at least ₦2.5 million or imprisonment. The existence of enforceable sanctions is critical because it converts biosafety from a guideline into a compliance system.

Approval itself is not administrative but scientific. Each crop undergoes multi-layered risk assessment covering allergenicity, toxicity, environmental interaction, biodiversity impact, effects on beneficial insects, and socio-economic implications. These assessments follow international protocols and are conducted before commercial release, not after adoption.

The implication is straightforward: Nigeria evaluates safety before exposure, unlike the perception that crops are released first and studied later.

The measurable outcomes of this regulatory discipline are already visible in agriculture. Nigeria has approved one genetically modified cowpea variety and TELA maize variety after full biosafety scrutiny.

Farmers using the improved cowpea report harvest increases from about 3–4 bags per hectare to more than 20 bags, while some report harvesting over 80 bags from 100 kilograms of seed. In addition to yield gains, pesticide use drops dramatically. Farmers spray once instead of multiple times, cutting chemical exposure, lowering production costs, improving farmers’ health, and saving the environment.

These changes are not projections but field results, demonstrating that adoption accelerates once farmers are confident the technology is regulated.

Nigeria’s structured approach also distinguishes it within Africa. Only a few countries on the continent have commercialised GM crops, even though the 2025 African agricultural trends report noted that the African biotechnology market is projected to grow from about $615 million in 2018 to roughly $871 million by 2030.

At the same time, African countries invest an average of just 3.8 percent of their national budgets in agriculture, far below continental commitments as contained in the Malabo Declaration.

This means productivity growth must come from efficiency, and regulated biotechnology provides that pathway. By combining legal control, scientific testing, and farmer education, Nigeria is positioning itself as one of the few countries attempting adoption through governance rather than persuasion.

Perhaps the strongest evidence of regulatory competence is behavioural change among farmers. Producers who previously lost harvests to pests are expanding cultivated areas after adopting approved seeds, moving from one hectare to five hectares, because the risk has been reduced.

Adoption decisions in agriculture are conservative; farmers rarely expand production unless outcomes are predictable. Their willingness to scale up indicates confidence not only in the seeds but in the system that approved them.

The broader significance is that biosafety regulation has become an economic instrument. When regulation is weak, technology adoption stalls regardless of potential. When regulation is credible, adoption grows gradually but sustainably.

Nigeria’s experience shows that biotechnology acceptance is not driven by advocacy campaigns alone but by transparent approval processes, enforceable law, and verifiable farm-level performance.

While public skepticism remains a barrier to GM crops adoption in Nigeria, some farmers are already testifying to the transformative potential of biotechnology.

Emmanuel Ogienomoh, owner of Rayfield Farms in Jigwada, Keffi, said his experience with Pod Borer Resistant Cowpea has been life changing. “I used to spend so much on pest control when farming local bean varieties. But after switching to PBR Cowpea, I harvested over 80 bags from 100 kg of seeds and sprayed them just once. The guidance I got from experts made all the difference,” Ogienomoh said.

Similarly, Sheriffdeen Bashir, a young farmer and returnee from Togo, said GM crops rekindled his passion for agriculture.

“Growing up, we lost much of our harvest to pests and drought. But with TELA Maize and PBR Cowpea, yields have improved remarkably. I’m now expanding from one hectare to five, and I hope to support more farmers and seed companies,” he said.

The interaction with various stakeholders reaffirmed the NBMA’s commitment to transparency, public engagement, and science-driven regulation of biotechnology in Nigeria.

Participants agreed that sustained collaboration among regulators, scientists, farmers, and the media is vital to bridging the information gap and harnessing biotechnology’s full potential for food security, economic growth, and sustainable development.

As awareness spreads among rural communities and students, the country is demonstrating that the real foundation of biotechnology adoption is not persuasion but regulatory competence — a prerequisite for using innovation to strengthen food security, farmer income, and national agricultural resilience.

Barrister Godwin Agbo, a legal practitioner wrote from Abuja.

Join Our Channels